11 resources
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth |
|---|---|---|---|---|---|---|---|---|---|
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-polymorphic-form | Polymorphic Form | trial-use | 2 | brr | 2025-07 | us | hl7 |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-drug-product-substance-impurity | Drug Substance Impurity | trial-use | 2 | brr | 2025-07 | us | hl7 |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-component-substance | Component Substance | trial-use | 2 | brr | 2025-07 | us | hl7 |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-drug-substance-characterisation | Drug Substance | trial-use | 2 | brr | 2025-07 | us | hl7 |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-routine-drug-substance | Drug Substance Handle | trial-use | 2 | brr | 2025-07 | us | hl7 |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-excipient | Excipient Drug Substance | trial-use | 2 | brr | 2025-07 | us | hl7 |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-drug-substance-nomenclature-structure | Substance General Information | trial-use | 2 | brr | 2025-07 | us | hl7 |
| hl7.fhir.uv.emedicinal-product-info | R5 | SubstanceDefinition-uv-epi | SubstanceDefinition (ePI) | trial-use | 2 | 2025-07 | uv | hl7 | |
| hl7.fhir.uv.pharm-quality | R5 | SubstanceDefinition-component-substance-drug-pq | SubstanceDefinition - Component Substance Drug PQ | active | brr | 2024-05 | uv | hl7 | |
| idmp.who-umc.org.fhir | R5 | SubstanceDefinition-pub | SubstanceDefinition for publication | active | 2025-06 | uv | |||
| hl7.fhir.us.spl | R5 | SubmittedIngredientDefinition | SubmittedIngredientDefinition | trial-use | 1 | brr | 2025-07 | us | hl7 |
FHIR